vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
35.22
-2.00 (-5.37%)
At close: Mar 6, 2026, 4:00 PM EST
35.41
+0.19 (0.54%)
After-hours: Mar 6, 2026, 4:04 PM EST
vTv Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for vTv Therapeutics stock have an average target of 55.25, with a low estimate of 47 and a high estimate of 67. The average target predicts an increase of 56.87% from the current stock price of 35.22.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 27, 2026.
Analyst Ratings
The average analyst rating for vTv Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 2 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 2 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $40 → $49 | Strong Buy | Maintains | $40 → $49 | +39.13% | Jan 27, 2026 |
| Roth Capital | Roth Capital | Strong Buy Initiates $58 | Strong Buy | Initiates | $58 | +64.68% | Jan 23, 2026 |
| TD Cowen | TD Cowen | Strong Buy Initiates $67 | Strong Buy | Initiates | $67 | +90.23% | Jan 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $47 | Strong Buy | Maintains | $36 → $47 | +33.45% | Dec 19, 2025 |
| BTIG | BTIG | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +13.57% | Nov 19, 2025 |
Financial Forecast
Revenue This Year
n/a
from 1.02M
Revenue Next Year
n/a
EPS This Year
-4.23
from -3.20
EPS Next Year
-4.06
from -4.23
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.52 | -1.34 | ||||
| Avg | -4.23 | -4.06 | ||||
| Low | -4.95 | -6.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.